| Year |
Citation |
Score |
| 2022 |
Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Corrigendum to "Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy" [Biomater. 234 (2020) 119760]. Biomaterials. 293: 121951. PMID 36525705 DOI: 10.1016/j.biomaterials.2022.121951 |
0.34 |
|
| 2022 |
Hornburg D, Ferdosi S, Stukalov A, Hasan M, Tangeysh B, Brown TR, Wang T, Elgierari EM, Zhao X, Huang Y, Alavi A, Lee-McMullen B, Chu J, Figa M, Tao W, ... ... Farokhzad OC, et al. Enhanced competition at the nano-bio interface enables comprehensive characterization of protein corona dynamics and deep coverage of proteomes. Advanced Materials (Deerfield Beach, Fla.). e2206008. PMID 35986672 DOI: 10.1002/adma.202206008 |
0.302 |
|
| 2022 |
Ferdosi S, Tangeysh B, Brown TR, Everley PA, Figa M, McLean M, Elgierari EM, Zhao X, Garcia VJ, Wang T, Chang MEK, Riedesel K, Chu J, Mahoney M, Xia H, ... ... Farokhzad OC, et al. Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano-bio interactions. Proceedings of the National Academy of Sciences of the United States of America. 119: e2106053119. PMID 35275789 DOI: 10.1073/pnas.2106053119 |
0.402 |
|
| 2022 |
Kamaly N, Farokhzad OC, Corbo C. Nanoparticle protein corona evolution: from biological impact to biomarker discovery. Nanoscale. 14: 1606-1620. PMID 35076049 DOI: 10.1039/d1nr06580g |
0.303 |
|
| 2020 |
Liu Y, Wang J, Xiong Q, Hornburg D, Tao W, Farokhzad OC. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection. Accounts of Chemical Research. PMID 33180454 DOI: 10.1021/acs.accounts.0c00413 |
0.352 |
|
| 2020 |
Corbo C, Li AA, Poustchi H, Lee GY, Stacks S, Molinaro R, Ma P, Platt T, Behzadi S, Langer R, Farias V, Farokhzad OC. Analysis of the Human Plasma Proteome Using Multi-Nanoparticle Protein Corona for Detection of Alzheimer's Disease. Advanced Healthcare Materials. e2000948. PMID 33169521 DOI: 10.1002/adhm.202000948 |
0.392 |
|
| 2020 |
Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nature Reviews. Materials. 1-14. PMID 33078077 DOI: 10.1038/s41578-020-00247-y |
0.306 |
|
| 2020 |
Tao W, Yurdagul A, Kong N, Li W, Wang X, Doran AC, Feng C, Wang J, Islam MA, Farokhzad OC, Tabas I, Shi J. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice. Science Translational Medicine. 12. PMID 32718990 DOI: 10.1126/Scitranslmed.Aay1063 |
0.303 |
|
| 2020 |
Blume JE, Manning WC, Troiano G, Hornburg D, Figa M, Hesterberg L, Platt TL, Zhao X, Cuaresma RA, Everley PA, Ko M, Liou H, Mahoney M, Ferdosi S, Elgierari EM, ... ... Farokhzad OC, et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nature Communications. 11: 3662. PMID 32699280 DOI: 10.1038/S41467-020-17033-7 |
0.409 |
|
| 2020 |
Blume JE, Manning WC, Troiano G, Hornburg D, Figa M, Hesterberg L, Platt TL, Zhao X, Cuaresma RA, Everley PA, Ko M, Liou H, Mahoney M, Ferdosi S, Elgierari EM, ... ... Farokhzad OC, et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona. Nature Communications. 11: 3662. PMID 32699280 DOI: 10.1038/S41467-020-17033-7 |
0.409 |
|
| 2020 |
Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. Biomaterials. 234: 119760. PMID 31945619 DOI: 10.1016/j.biomaterials.2020.119760 |
0.449 |
|
| 2020 |
Li S, Saw PE, Lin C, Nie Y, Tao W, Farokhzad OC, Zhang L, Xu X. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. Biomaterials. 234: 119760. PMID 31945619 DOI: 10.1016/j.biomaterials.2020.119760 |
0.449 |
|
| 2019 |
Saw PE, Yao H, Lin C, Tao W, Farokhzad OC, Xu X. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy. Nano Letters. PMID 31381852 DOI: 10.1021/acs.nanolett.9b01660 |
0.394 |
|
| 2019 |
Saw PE, Yao H, Lin C, Tao W, Farokhzad OC, Xu X. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy. Nano Letters. PMID 31381852 DOI: 10.1021/acs.nanolett.9b01660 |
0.394 |
|
| 2018 |
Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, ... ... Farokhzad OC, et al. Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2: 968. PMID 31015729 DOI: 10.1038/S41551-018-0331-X |
0.385 |
|
| 2018 |
Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, ... ... Farokhzad OC, et al. Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2: 968. PMID 31015729 DOI: 10.1038/S41551-018-0331-X |
0.385 |
|
| 2018 |
Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, ... ... Farokhzad OC, et al. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2: 850-864. PMID 31015614 DOI: 10.1038/S41551-018-0284-0 |
0.408 |
|
| 2018 |
Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, ... ... Farokhzad OC, et al. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2: 850-864. PMID 31015614 DOI: 10.1038/S41551-018-0284-0 |
0.408 |
|
| 2018 |
Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, ... ... Farokhzad OC, et al. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Theranostics. 8: 6008-6024. PMID 30613278 DOI: 10.7150/Thno.24365 |
0.358 |
|
| 2018 |
Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, ... ... Farokhzad OC, et al. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Theranostics. 8: 6008-6024. PMID 30613278 DOI: 10.7150/Thno.24365 |
0.358 |
|
| 2018 |
Lim JM, Cai T, Mandaric S, Chopra S, Han H, Jang S, Il Choi W, Langer R, Farokhzad OC, Karnik R. Drug loading augmentation in polymeric nanoparticles using a coaxial turbulent jet mixer: Yong investigator perspective. Journal of Colloid and Interface Science. 538: 45-50. PMID 30500466 DOI: 10.1016/J.Jcis.2018.11.029 |
0.501 |
|
| 2018 |
Lim JM, Cai T, Mandaric S, Chopra S, Han H, Jang S, Il Choi W, Langer R, Farokhzad OC, Karnik R. Drug loading augmentation in polymeric nanoparticles using a coaxial turbulent jet mixer: Yong investigator perspective. Journal of Colloid and Interface Science. 538: 45-50. PMID 30500466 DOI: 10.1016/J.Jcis.2018.11.029 |
0.501 |
|
| 2018 |
Ling X, Tu J, Wang J, Shajii A, Kong N, Feng C, Zhang Y, Yu M, Xie T, Bharwani Z, Aljaeid BM, Shi B, Tao W, Farokhzad OC. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy. Acs Nano. PMID 30485068 DOI: 10.1021/acsnano.8b06400 |
0.424 |
|
| 2018 |
Ling X, Tu J, Wang J, Shajii A, Kong N, Feng C, Zhang Y, Yu M, Xie T, Bharwani Z, Aljaeid BM, Shi B, Tao W, Farokhzad OC. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy. Acs Nano. PMID 30485068 DOI: 10.1021/acsnano.8b06400 |
0.424 |
|
| 2018 |
Xu X, Wu J, Liu S, Saw PE, Tao W, Li Y, Krygsman L, Yegnasubramanian S, De Marzo AM, Shi J, Bieberich CJ, Farokhzad OC. Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. Small (Weinheim An Der Bergstrasse, Germany). e1802565. PMID 30230235 DOI: 10.1002/Smll.201802565 |
0.405 |
|
| 2018 |
Xu X, Wu J, Liu S, Saw PE, Tao W, Li Y, Krygsman L, Yegnasubramanian S, De Marzo AM, Shi J, Bieberich CJ, Farokhzad OC. Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. Small (Weinheim An Der Bergstrasse, Germany). e1802565. PMID 30230235 DOI: 10.1002/Smll.201802565 |
0.405 |
|
| 2018 |
Lin X, Chen X, Riddell IA, Tao W, Wang J, Hollett G, Lippard SJ, Farokhzad OC, Shi J, Wu J. Glutathione-scavenging Poly(disulfide amide) Nanoparticles for Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance. Nano Letters. PMID 29902013 DOI: 10.1021/Acs.Nanolett.8B01924 |
0.377 |
|
| 2018 |
Lin X, Chen X, Riddell IA, Tao W, Wang J, Hollett G, Lippard SJ, Farokhzad OC, Shi J, Wu J. Glutathione-scavenging Poly(disulfide amide) Nanoparticles for Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance. Nano Letters. PMID 29902013 DOI: 10.1021/Acs.Nanolett.8B01924 |
0.377 |
|
| 2017 |
Kakkar A, Traverso G, Farokhzad OC, Weissleder R, Langer R. Evolution of macromolecular complexity in drug delivery systems. Nature Reviews. Chemistry. 1. PMID 31286060 DOI: 10.1038/s41570-017-0063 |
0.428 |
|
| 2017 |
Kakkar A, Traverso G, Farokhzad OC, Weissleder R, Langer R. Evolution of macromolecular complexity in drug delivery systems. Nature Reviews. Chemistry. 1. PMID 31286060 DOI: 10.1038/s41570-017-0063 |
0.428 |
|
| 2017 |
Bertrand N, Grenier P, Mahmoudi M, Lima EM, Appel EA, Dormont F, Lim JM, Karnik R, Langer R, Farokhzad OC. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nature Communications. 8: 777. PMID 28974673 DOI: 10.1038/S41467-017-00600-W |
0.484 |
|
| 2017 |
Bertrand N, Grenier P, Mahmoudi M, Lima EM, Appel EA, Dormont F, Lim JM, Karnik R, Langer R, Farokhzad OC. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nature Communications. 8: 777. PMID 28974673 DOI: 10.1038/S41467-017-00600-W |
0.484 |
|
| 2017 |
Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, ... ... Farokhzad OC, et al. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr(-/-) Mice. Advanced Healthcare Materials. PMID 28730752 DOI: 10.1002/Adhm.201700313 |
0.342 |
|
| 2017 |
Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, ... ... Farokhzad OC, et al. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr(-/-) Mice. Advanced Healthcare Materials. PMID 28730752 DOI: 10.1002/Adhm.201700313 |
0.342 |
|
| 2017 |
Xu X, Saw PE, Tao W, Li Y, Ji X, Bhasin S, Liu Y, Ayyash D, Rasmussen J, Huo M, Shi J, Farokhzad OC. ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy. Advanced Materials (Deerfield Beach, Fla.). PMID 28681981 DOI: 10.1002/Adma.201700141 |
0.47 |
|
| 2017 |
Xu X, Saw PE, Tao W, Li Y, Ji X, Bhasin S, Liu Y, Ayyash D, Rasmussen J, Huo M, Shi J, Farokhzad OC. ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy. Advanced Materials (Deerfield Beach, Fla.). PMID 28681981 DOI: 10.1002/Adma.201700141 |
0.47 |
|
| 2017 |
Zhu X, Tao W, Liu D, Wu J, Guo Z, Ji X, Bharwani Z, Zhao L, Zhao X, Farokhzad OC, Shi J. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo. Theranostics. 7: 1990-2002. PMID 28638484 DOI: 10.7150/Thno.18136 |
0.369 |
|
| 2017 |
Zhu X, Tao W, Liu D, Wu J, Guo Z, Ji X, Bharwani Z, Zhao L, Zhao X, Farokhzad OC, Shi J. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo. Theranostics. 7: 1990-2002. PMID 28638484 DOI: 10.7150/Thno.18136 |
0.369 |
|
| 2017 |
Xu X, Saw PE, Tao W, Li Y, Ji X, Yu M, Mahmoudi M, Rasmussen J, Ayyash D, Zhou Y, Farokhzad OC, Shi J. Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. Nano Letters. PMID 28636389 DOI: 10.1021/Acs.Nanolett.7B01571 |
0.382 |
|
| 2017 |
Xu X, Saw PE, Tao W, Li Y, Ji X, Yu M, Mahmoudi M, Rasmussen J, Ayyash D, Zhou Y, Farokhzad OC, Shi J. Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. Nano Letters. PMID 28636389 DOI: 10.1021/Acs.Nanolett.7B01571 |
0.382 |
|
| 2017 |
Chopra S, Bertrand N, Lim JM, Wang A, Farokhzad OC, Karnik R. Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation. Acs Applied Materials & Interfaces. PMID 28323414 DOI: 10.1021/Acsami.6B16854 |
0.312 |
|
| 2017 |
Chopra S, Bertrand N, Lim JM, Wang A, Farokhzad OC, Karnik R. Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation. Acs Applied Materials & Interfaces. PMID 28323414 DOI: 10.1021/Acsami.6B16854 |
0.312 |
|
| 2017 |
Xu X, Wu J, Liu Y, Saw PE, Tao W, Yu M, Zope HR, Si M, Victorious A, Rasmussen J, Ayyash D, Farokhzad OC, Shi J. A Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. Acs Nano. PMID 28240870 DOI: 10.1021/Acsnano.6B07195 |
0.392 |
|
| 2017 |
Xu X, Wu J, Liu Y, Saw PE, Tao W, Yu M, Zope HR, Si M, Victorious A, Rasmussen J, Ayyash D, Farokhzad OC, Shi J. A Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy. Acs Nano. PMID 28240870 DOI: 10.1021/Acsnano.6B07195 |
0.392 |
|
| 2017 |
Saw PE, Yu M, Choi M, Lee E, Jon S, Farokhzad OC. Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy. Biomaterials. 123: 118-126. PMID 28167390 DOI: 10.1016/j.biomaterials.2017.01.040 |
0.362 |
|
| 2017 |
Saw PE, Yu M, Choi M, Lee E, Jon S, Farokhzad OC. Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy. Biomaterials. 123: 118-126. PMID 28167390 DOI: 10.1016/j.biomaterials.2017.01.040 |
0.362 |
|
| 2017 |
Caracciolo G, Farokhzad OC, Mahmoudi M. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. Trends in Biotechnology. 35: 257-264. PMID 27663778 DOI: 10.1016/j.tibtech.2016.08.011 |
0.358 |
|
| 2017 |
Caracciolo G, Farokhzad OC, Mahmoudi M. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. Trends in Biotechnology. 35: 257-264. PMID 27663778 DOI: 10.1016/j.tibtech.2016.08.011 |
0.358 |
|
| 2016 |
Cisterna BA, Kamaly N, Choi WI, Tavakkoli A, Farokhzad OC, Vilos C. Targeted nanoparticles for colorectal cancer. Nanomedicine (London, England). PMID 27529192 DOI: 10.2217/nnm-2016-0194 |
0.42 |
|
| 2016 |
Liu Y, Gunda V, Zhu X, Xu X, Wu J, Askhatova D, Farokhzad OC, Parangi S, Shi J. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 27342857 DOI: 10.1073/Pnas.1605841113 |
0.324 |
|
| 2016 |
Xue Y, Xu X, Zhang XQ, Farokhzad OC, Langer R. Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proceedings of the National Academy of Sciences of the United States of America. PMID 27140638 DOI: 10.1073/Pnas.1603840113 |
0.411 |
|
| 2016 |
Xu X, Wu J, Liu Y, Yu M, Zhao L, Zhu X, Bhasin S, Li Q, Ha E, Shi J, Farokhzad OC. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy. Angewandte Chemie (International Ed. in English). PMID 27140428 DOI: 10.1002/Anie.201601273 |
0.331 |
|
| 2016 |
Kamaly N, Fredman G, Fojas JJ, Subramanian M, Choi WI, Zepeda K, Vilos C, Yu M, Gadde S, Wu J, Milton J, Carvalho Leitao R, Rosa Fernandes L, Hasan M, Gao H, ... ... Farokhzad OC, et al. Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis. Acs Nano. PMID 27100066 DOI: 10.1021/Acsnano.6B01114 |
0.331 |
|
| 2016 |
Zhu X, Wu J, Shan W, Tao W, Zhao L, Lim JM, D'Ortenzio M, Karnik R, Huang Y, Shi J, Farokhzad OC. Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins. Angewandte Chemie (International Ed. in English). PMID 26846161 DOI: 10.1002/Anie.201509183 |
0.366 |
|
| 2016 |
Zhu X, Wu J, Shan W, Tao W, Zhao L, Lim JM, D'Ortenzio M, Karnik R, Huang Y, Shi J, Farokhzad OC. Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins. Angewandte Chemie (International Ed. in English). PMID 26846161 DOI: 10.1002/Anie.201509183 |
0.366 |
|
| 2015 |
Chung BL, Toth MJ, Kamaly N, Sei YJ, Becraft J, Mulder WJ, Fayad ZA, Farokhzad OC, Kim Y, Langer R. Nanomedicines for Endothelial Disorders. Nano Today. 10: 759-776. PMID 26955397 DOI: 10.1016/J.Nantod.2015.11.009 |
0.319 |
|
| 2015 |
Chung BL, Toth MJ, Kamaly N, Sei YJ, Becraft J, Mulder WJ, Fayad ZA, Farokhzad OC, Kim Y, Langer R. Nanomedicines for Endothelial Disorders. Nano Today. 10: 759-776. PMID 26955397 DOI: 10.1016/J.Nantod.2015.11.009 |
0.319 |
|
| 2015 |
Miller MA, Gadde S, Pfirschke C, Engblom C, Sprachman MM, Kohler RH, Yang KS, Laughney AM, Wojtkiewicz G, Kamaly N, Bhonagiri S, Pittet MJ, Farokhzad OC, Weissleder R. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Science Translational Medicine. 7: 314ra183. PMID 26582898 DOI: 10.1126/Scitranslmed.Aac6522 |
0.319 |
|
| 2015 |
Miller MA, Gadde S, Pfirschke C, Engblom C, Sprachman MM, Kohler RH, Yang KS, Laughney AM, Wojtkiewicz G, Kamaly N, Bhonagiri S, Pittet MJ, Farokhzad OC, Weissleder R. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Science Translational Medicine. 7: 314ra183. PMID 26582898 DOI: 10.1126/Scitranslmed.Aac6522 |
0.319 |
|
| 2015 |
Miller MA, Zheng YR, Gadde S, Pfirschke C, Zope H, Engblom C, Kohler RH, Iwamoto Y, Yang KS, Askevold B, Kolishetti N, Pittet M, Lippard SJ, Farokhzad OC, Weissleder R. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nature Communications. 6: 8692. PMID 26503691 DOI: 10.1038/Ncomms9692 |
0.694 |
|
| 2015 |
Yameen B, Vilos C, Choi WI, Whyte A, Huang J, Pollit L, Farokhzad OC. Drug Delivery Nanocarriers from a Fully Degradable PEG-Conjugated Polyester with a Reduction-Responsive Backbone. Chemistry (Weinheim An Der Bergstrasse, Germany). 21: 11325-9. PMID 26177931 DOI: 10.1002/chem.201502233 |
0.337 |
|
| 2015 |
Wu J, Zhao L, Xu X, Bertrand N, Choi WI, Yameen B, Shi J, Shah V, Mulvale M, MacLean JL, Farokhzad OC. Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics. Angewandte Chemie (International Ed. in English). PMID 26119453 DOI: 10.1002/Anie.201503863 |
0.441 |
|
| 2015 |
Zhu X, Xu Y, Solis LM, Tao W, Wang L, Behrens C, Xu X, Zhao L, Liu D, Wu J, Zhang N, Wistuba II, Farokhzad OC, Zetter BR, Shi J. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proceedings of the National Academy of Sciences of the United States of America. 112: 7779-84. PMID 26056316 DOI: 10.1073/Pnas.1505629112 |
0.398 |
|
| 2015 |
Saw PE, Park J, Lee E, Ahn S, Lee J, Kim H, Kim J, Choi M, Farokhzad OC, Jon S. Effect of PEG pairing on the efficiency of cancer-targeting liposomes. Theranostics. 5: 746-54. PMID 25897339 DOI: 10.7150/Thno.10732 |
0.334 |
|
| 2015 |
Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opinion On Drug Delivery. 12: 1459-73. PMID 25813361 DOI: 10.1517/17425247.2015.1018175 |
0.395 |
|
| 2015 |
Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opinion On Drug Delivery. 12: 1459-73. PMID 25813361 DOI: 10.1517/17425247.2015.1018175 |
0.395 |
|
| 2015 |
Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, Argyris I, Rijcken E, Kusters D, Reutelingsperger C, Perretti M, ... ... Farokhzad OC, et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. The Journal of Clinical Investigation. 125: 1215-27. PMID 25664854 DOI: 10.1172/Jci76693 |
0.3 |
|
| 2015 |
Xu X, Ho W, Zhang X, Bertrand N, Farokhzad O. Cancer nanomedicine: from targeted delivery to combination therapy. Trends in Molecular Medicine. 21: 223-32. PMID 25656384 DOI: 10.1016/J.Molmed.2015.01.001 |
0.439 |
|
| 2015 |
Maldonado RA, LaMothe RA, Ferrari JD, Zhang AH, Rossi RJ, Kolte PN, Griset AP, O'Neil C, Altreuter DH, Browning E, Johnston L, Farokhzad OC, Langer R, Scott DW, von Andrian UH, et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proceedings of the National Academy of Sciences of the United States of America. 112: E156-65. PMID 25548186 DOI: 10.1073/Pnas.1408686111 |
0.415 |
|
| 2015 |
Zhang XQ, Even-Or O, Xu X, van Rosmalen M, Lim L, Gadde S, Farokhzad OC, Fisher EA. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis. Advanced Healthcare Materials. 4: 228-36. PMID 25156796 DOI: 10.1002/Adhm.201400337 |
0.341 |
|
| 2014 |
Choi WI, Kamaly N, Riol-Blanco L, Lee IH, Wu J, Swami A, Vilos C, Yameen B, Yu M, Shi J, Tabas I, von Andrian UH, Jon S, Farokhzad OC. A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins. Nano Letters. 14: 6449-55. PMID 25333768 DOI: 10.1021/Nl502994Y |
0.321 |
|
| 2014 |
Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW, Farokhzad OC. Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. Angewandte Chemie (International Ed. in English). 53: 8975-9. PMID 24990548 DOI: 10.1002/Anie.201404766 |
0.335 |
|
| 2014 |
Yameen B, Choi WI, Vilos C, Swami A, Shi J, Farokhzad OC. Insight into nanoparticle cellular uptake and intracellular targeting. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 485-99. PMID 24984011 DOI: 10.1016/J.Jconrel.2014.06.038 |
0.375 |
|
| 2014 |
Swami A, Reagan MR, Basto P, Mishima Y, Kamaly N, Glavey S, Zhang S, Moschetta M, Seevaratnam D, Zhang Y, Liu J, Memarzadeh M, Wu J, Manier S, Shi J, ... ... Farokhzad OC, et al. Engineered nanomedicine for myeloma and bone microenvironment targeting. Proceedings of the National Academy of Sciences of the United States of America. 111: 10287-92. PMID 24982170 DOI: 10.1073/Pnas.1401337111 |
0.368 |
|
| 2014 |
Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle technologies for oral drug delivery. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 12: 1605-10. PMID 24981782 DOI: 10.1016/j.cgh.2014.06.018 |
0.333 |
|
| 2014 |
Pridgen EM, Alexis F, Farokhzad OC. Polymeric nanoparticle technologies for oral drug delivery. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 12: 1605-10. PMID 24981782 DOI: 10.1016/j.cgh.2014.06.018 |
0.333 |
|
| 2014 |
Lim JM, Swami A, Gilson LM, Chopra S, Choi S, Wu J, Langer R, Karnik R, Farokhzad OC. Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixer. Acs Nano. 8: 6056-65. PMID 24824296 DOI: 10.1021/Nn501371N |
0.464 |
|
| 2014 |
Gadde S, Even-Or O, Kamaly N, Hasija A, Gagnon PG, Adusumilli KH, Erakovic A, Pal AK, Zhang XQ, Kolishetti N, Shi J, Fisher EA, Farokhzad OC. Development of therapeutic polymeric nanoparticles for the resolution of inflammation. Advanced Healthcare Materials. 3: 1448-56. PMID 24659608 DOI: 10.1002/Adhm.201300688 |
0.696 |
|
| 2014 |
Shi J, Xu Y, Xu X, Zhu X, Pridgen E, Wu J, Votruba AR, Swami A, Zetter BR, Farokhzad OC. Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 897-900. PMID 24650883 DOI: 10.1016/J.Nano.2014.03.006 |
0.373 |
|
| 2014 |
Ilyinskii PO, Roy CJ, O'Neil CP, Browning EA, Pittet LA, Altreuter DH, Alexis F, Tonti E, Shi J, Basto PA, Iannacone M, Radovic-Moreno AF, Langer RS, Farokhzad OC, von Andrian UH, et al. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine. 32: 2882-95. PMID 24593999 DOI: 10.1016/J.Vaccine.2014.02.027 |
0.402 |
|
| 2014 |
Kim Y, Lobatto ME, Kawahara T, Lee Chung B, Mieszawska AJ, Sanchez-Gaytan BL, Fay F, Senders ML, Calcagno C, Becraft J, Tun Saung M, Gordon RE, Stroes ES, Ma M, Farokhzad OC, et al. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 111: 1078-83. PMID 24395808 DOI: 10.1073/Pnas.1322725111 |
0.481 |
|
| 2014 |
Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews. 66: 2-25. PMID 24270007 DOI: 10.1016/J.Addr.2013.11.009 |
0.409 |
|
| 2014 |
Lim JM, Bertrand N, Valencia PM, Rhee M, Langer R, Jon S, Farokhzad OC, Karnik R. Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study Nanomedicine: Nanotechnology, Biology, and Medicine. 10: 401-409. PMID 23969105 DOI: 10.1016/J.Nano.2013.08.003 |
0.461 |
|
| 2013 |
Pridgen EM, Alexis F, Kuo TT, Levy-Nissenbaum E, Karnik R, Blumberg RS, Langer R, Farokhzad OC. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Science Translational Medicine. 5: 213ra167. PMID 24285486 DOI: 10.1126/Scitranslmed.3007049 |
0.479 |
|
| 2013 |
Valencia PM, Pridgen EM, Rhee M, Langer R, Farokhzad OC, Karnik R. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. Acs Nano. 7: 10671-80. PMID 24215426 DOI: 10.1021/Nn403370E |
0.532 |
|
| 2013 |
Xu X, Xie K, Zhang XQ, Pridgen EM, Park GY, Cui DS, Shi J, Wu J, Kantoff PW, Lippard SJ, Langer R, Walker GC, Farokhzad OC. Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug. Proceedings of the National Academy of Sciences of the United States of America. 110: 18638-43. PMID 24167294 DOI: 10.1073/Pnas.1303958110 |
0.465 |
|
| 2013 |
Kim Y, Fay F, Cormode DP, Sanchez-Gaytan BL, Tang J, Hennessy EJ, Ma M, Moore K, Farokhzad OC, Fisher EA, Mulder WJ, Langer R, Fayad ZA. Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics. Acs Nano. 7: 9975-83. PMID 24079940 DOI: 10.1021/Nn4039063 |
0.394 |
|
| 2013 |
Mieszawska AJ, Kim Y, Gianella A, van Rooy I, Priem B, Labarre MP, Ozcan C, Cormode DP, Petrov A, Langer R, Farokhzad OC, Fayad ZA, Mulder WJ. Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy. Bioconjugate Chemistry. 24: 1429-34. PMID 23957728 DOI: 10.1021/Bc400166J |
0.547 |
|
| 2013 |
Gianella A, Mieszawska AJ, Hoeben FJM, Janssen HM, Jarzyna PA, Cormode DP, Costa KD, Rao S, Farokhzad OC, Langer R, Fayad ZA, Mulder WJM. Synthesis and in vitro evaluation of a multifunctional and surface-switchable nanoemulsion platform Chemical Communications. 49: 9392-9394. PMID 23877789 DOI: 10.1039/C3Cc43618G |
0.403 |
|
| 2013 |
Johnstone TC, Kulak N, Pridgen EM, Farokhzad OC, Langer R, Lippard SJ. Nanoparticle encapsulation of mitaplatin and the effect thereof on in vivo properties. Acs Nano. 7: 5675-83. PMID 23697579 DOI: 10.1021/Nn401905G |
0.543 |
|
| 2013 |
Kamaly N, Fredman G, Subramanian M, Gadde S, Pesic A, Cheung L, Fayad ZA, Langer R, Tabas I, Farokhzad OC. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proceedings of the National Academy of Sciences of the United States of America. 110: 6506-11. PMID 23533277 DOI: 10.1073/Pnas.1303377110 |
0.479 |
|
| 2013 |
Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Research. 73: 2412-7. PMID 23423979 DOI: 10.1158/0008-5472.Can-12-4561 |
0.303 |
|
| 2013 |
Salvador-Morales C, Valencia PM, Gao W, Karnik R, Farokhzad OC. Spontaneous formation of heterogeneous patches on polymer-lipid core-shell particle surfaces during self-assembly. Small (Weinheim An Der Bergstrasse, Germany). 9: 511-7. PMID 23109494 DOI: 10.1002/Smll.201201499 |
0.311 |
|
| 2013 |
Valencia PM, Pridgen EM, Perea B, Gadde S, Sweeney C, Kantoff PW, Bander NH, Lippard SJ, Langer R, Karnik R, Farokhzad OC. Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles. Nanomedicine (London, England). 8: 687-98. PMID 23075285 DOI: 10.2217/Nnm.12.134 |
0.552 |
|
| 2012 |
Valencia PM, Farokhzad OC, Karnik R, Langer R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nature Nanotechnology. 7: 623-9. PMID 23042546 DOI: 10.1038/Nnano.2012.168 |
0.496 |
|
| 2012 |
Kim Y, Lee Chung B, Ma M, Mulder WJ, Fayad ZA, Farokhzad OC, Langer R. Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. Nano Letters. 12: 3587-91. PMID 22716029 DOI: 10.1021/Nl301253V |
0.469 |
|
| 2012 |
Graf N, Bielenberg DR, Kolishetti N, Muus C, Banyard J, Farokhzad OC, Lippard SJ. α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. Acs Nano. 6: 4530-9. PMID 22584163 DOI: 10.1021/Nn301148E |
0.729 |
|
| 2012 |
Xiao Z, Farokhzad OC. Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. Acs Nano. 6: 3670-6. PMID 22574989 DOI: 10.1021/nn301869z |
0.344 |
|
| 2012 |
Mieszawska AJ, Gianella A, Cormode DP, Zhao Y, Meijerink A, Langer R, Farokhzad OC, Fayad ZA, Mulder WJ. Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging. Chemical Communications (Cambridge, England). 48: 5835-7. PMID 22555311 DOI: 10.1039/C2Cc32149A |
0.449 |
|
| 2012 |
Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M, Horhota A, Low S, McDonnell K, Peeke E, Retnarajan B, Sabnis A, ... ... Farokhzad OC, et al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Science Translational Medicine. 4: 128ra39. PMID 22491949 DOI: 10.1126/Scitranslmed.3003651 |
0.432 |
|
| 2012 |
Radovic-Moreno AF, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. Acs Nano. 6: 4279-87. PMID 22471841 DOI: 10.1021/Nn3008383 |
0.481 |
|
| 2012 |
Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chemical Society Reviews. 41: 2971-3010. PMID 22388185 DOI: 10.1039/c2cs15344k |
0.331 |
|
| 2012 |
Xiao Z, Levy-Nissenbaum E, Alexis F, Lupták A, Teply BA, Chan JM, Shi J, Digga E, Cheng J, Langer R, Farokhzad OC. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. Acs Nano. 6: 696-704. PMID 22214176 DOI: 10.1021/Nn204165V |
0.527 |
|
| 2012 |
Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs Annual Review of Medicine. 63: 185-198. PMID 21888516 DOI: 10.1146/Annurev-Med-040210-162544 |
0.522 |
|
| 2011 |
Chan JM, Rhee JW, Drum CL, Bronson RT, Golomb G, Langer R, Farokhzad OC. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proceedings of the National Academy of Sciences of the United States of America. 108: 19347-52. PMID 22087004 DOI: 10.1073/Pnas.1115945108 |
0.465 |
|
| 2011 |
Shi J, Xiao Z, Kamaly N, Farokhzad OC. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Accounts of Chemical Research. 44: 1123-34. PMID 21692448 DOI: 10.1021/Ar200054N |
0.441 |
|
| 2011 |
Valencia PM, Hanewich-Hollatz MH, Gao W, Karim F, Langer R, Karnik R, Farokhzad OC. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. Biomaterials. 32: 6226-33. PMID 21658757 DOI: 10.1016/J.Biomaterials.2011.04.078 |
0.523 |
|
| 2011 |
Rhee M, Valencia PM, Rodriguez MI, Langer R, Farokhzad OC, Karnik R. Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels. Advanced Materials (Deerfield Beach, Fla.). 23: H79-83. PMID 21433105 DOI: 10.1002/Adma.201004333 |
0.575 |
|
| 2011 |
Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proceedings of the National Academy of Sciences of the United States of America. 108: 1850-5. PMID 21233423 DOI: 10.1073/Pnas.1011379108 |
0.711 |
|
| 2010 |
Burgess P, Hutt PB, Farokhzad OC, Langer R, Minick S, Zale S. On firm ground: IP protection of therapeutic nanoparticles Nature Biotechnology. 28: 1267-1270. PMID 21139609 DOI: 10.1038/Nbt.1725 |
0.453 |
|
| 2010 |
Kolishetti N, Dhar S, Valencia PM, Lin LQ, Karnik R, Lippard SJ, Langer R, Farokhzad OC. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proceedings of the National Academy of Sciences of the United States of America. 107: 17939-44. PMID 20921363 DOI: 10.1073/Pnas.1011368107 |
0.764 |
|
| 2010 |
Gao W, Chan JM, Farokhzad OC. pH-Responsive nanoparticles for drug delivery. Molecular Pharmaceutics. 7: 1913-20. PMID 20836539 DOI: 10.1021/mp100253e |
0.391 |
|
| 2010 |
Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Letters. 10: 3223-30. PMID 20726522 DOI: 10.1021/Nl102184C |
0.375 |
|
| 2010 |
Gao W, Langer R, Farokhzad OC. Poly(ethylene glycol) with observable shedding. Angewandte Chemie (International Ed. in English). 49: 6567-71. PMID 20677297 DOI: 10.1002/Anie.201001868 |
0.43 |
|
| 2010 |
Wang AZ, Yuet K, Zhang L, Gu FX, Huynh-Le M, Radovic-Moreno AF, Kantoff PW, Bander NH, Langer R, Farokhzad OC. ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. Nanomedicine (London, England). 5: 361-8. PMID 20394530 DOI: 10.2217/Nnm.10.6 |
0.542 |
|
| 2010 |
Gao W, Xiao Z, Radovic-Moreno A, Shi J, Langer R, Farokhzad OC. Progress in siRNA delivery using multifunctional nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 629: 53-67. PMID 20387142 DOI: 10.1007/978-1-60761-657-3_4 |
0.5 |
|
| 2010 |
Chan JM, Valencia PM, Zhang L, Langer R, Farokhzad OC. Polymeric nanoparticles for drug delivery. Methods in Molecular Biology (Clifton, N.J.). 624: 163-75. PMID 20217595 DOI: 10.1007/978-1-60761-609-2_11 |
0.579 |
|
| 2010 |
Alexis F, Pridgen EM, Langer R, Farokhzad OC. Nanoparticle Technologies for Cancer Therapy Handbook of Experimental Pharmacology. 197: 55-86. PMID 20217526 DOI: 10.1007/978-3-642-00477-3_2 |
0.523 |
|
| 2010 |
Valencia PM, Basto PA, Zhang L, Rhee M, Langer R, Farokhzad OC, Karnik R. Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixing. Acs Nano. 4: 1671-9. PMID 20166699 DOI: 10.1021/Nn901433U |
0.485 |
|
| 2010 |
Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Langer R, von Andrian U, Farokhzad OC. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (London, England). 5: 269-85. PMID 20148638 DOI: 10.2217/Nnm.10.1 |
0.636 |
|
| 2010 |
Chan JM, Zhang L, Tong R, Ghosh D, Gao W, Liao G, Yuet KP, Gray D, Rhee JW, Cheng J, Golomb G, Libby P, Langer R, Farokhzad OC. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proceedings of the National Academy of Sciences of the United States of America. 107: 2213-8. PMID 20133865 DOI: 10.1073/Pnas.0914585107 |
0.516 |
|
| 2009 |
Gu F, Langer RS, Farokhzad OC. Formulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery. Methods of Molecular Biology. 544: 589-598. PMID 19488725 DOI: 10.1007/978-1-59745-483-4_37 |
0.528 |
|
| 2009 |
Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. Acs Nano. 3: 16-20. PMID 19206243 DOI: 10.1021/nn900002m |
0.385 |
|
| 2009 |
Salvador-Morales C, Gao W, Ghatalia P, Murshed F, Aizu W, Langer R, Farokhzad OC. Multifunctional nanoparticles for prostate cancer therapy. Expert Review of Anticancer Therapy. 9: 211-21. PMID 19192959 DOI: 10.1586/14737140.9.2.211 |
0.464 |
|
| 2009 |
Salvador-Morales C, Zhang L, Langer R, Farokhzad OC. Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials. 30: 2231-40. PMID 19167749 DOI: 10.1016/J.Biomaterials.2009.01.005 |
0.456 |
|
| 2009 |
Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 30: 1627-34. PMID 19111339 DOI: 10.1016/J.Biomaterials.2008.12.013 |
0.538 |
|
| 2008 |
Zhang L, Chan JM, Gu FX, Rhee JW, Wang AZ, Radovic-Moreno AF, Alexis F, Langer R, Farokhzad OC. Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. Acs Nano. 2: 1696-702. PMID 19206374 DOI: 10.1021/Nn800275R |
0.522 |
|
| 2008 |
Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno AF, Zhang L, Pridgen E, Wang AZ, Marein SL, Westerhof K, Molnar LK, Farokhzad OC. HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. Chemmedchem. 3: 1839-43. PMID 19012296 DOI: 10.1002/Cmdc.200800122 |
0.473 |
|
| 2008 |
Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular Pharmaceutics. 5: 505-15. PMID 18672949 DOI: 10.1021/mp800051m |
0.301 |
|
| 2008 |
Karnik R, Gu F, Basto P, Cannizzaro C, Dean L, Kyei-Manu W, Langer R, Farokhzad OC. Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles Nano Letters. 8: 2906-2912. PMID 18656990 DOI: 10.1021/Nl801736Q |
0.488 |
|
| 2008 |
Wang AZ, Gu F, Zhang L, Chan JM, Radovic-Moreno A, Shaikh MR, Farokhzad OC. Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opinion On Biological Therapy. 8: 1063-70. PMID 18613759 DOI: 10.1517/14712598.8.8.1063 |
0.382 |
|
| 2008 |
Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L, Shaikh M, Yuet K, Cima MJ, Langer R, Kantoff PW, Bander NH, Jon S, Farokhzad OC. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. Chemmedchem. 3: 1311-5. PMID 18613203 DOI: 10.1002/Cmdc.200800091 |
0.436 |
|
| 2008 |
Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC. Nanotechnology and aptamers: applications in drug delivery Trends in Biotechnology. 26: 442-449. PMID 18571753 DOI: 10.1016/J.Tibtech.2008.04.006 |
0.399 |
|
| 2008 |
Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF, Langer R, Farokhzad OC. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proceedings of the National Academy of Sciences of the United States of America. 105: 2586-91. PMID 18272481 DOI: 10.1073/Pnas.0711714105 |
0.553 |
|
| 2008 |
Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urologic Oncology. 26: 74-85. PMID 18190835 DOI: 10.1016/J.Urolonc.2007.03.017 |
0.478 |
|
| 2008 |
Teply BA, Tong R, Jeong SY, Luther G, Sherifi I, Yim CH, Khademhosseini A, Farokhzad OC, Langer RS, Cheng J. The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules. Biomaterials. 29: 1216-23. PMID 18082254 DOI: 10.1016/J.Biomaterials.2007.11.018 |
0.357 |
|
| 2007 |
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology. 2: 751-60. PMID 18654426 DOI: 10.1038/Nnano.2007.387 |
0.386 |
|
| 2007 |
Pridgen EM, Langer R, Farokhzad OC. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy Nanomedicine: Nanotechnology, Biology and Medicine. 2: 669-680. PMID 17976029 DOI: 10.2217/17435889.2.5.669 |
0.531 |
|
| 2007 |
Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, Farokhzad OC. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Letters. 7: 3065-70. PMID 17854227 DOI: 10.1021/Nl071546N |
0.416 |
|
| 2007 |
Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, Bagalkot V, Jon S, Langer RS, Farokhzad OC. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. Chemmedchem. 2: 1268-71. PMID 17600796 DOI: 10.1002/Cmdc.200700121 |
0.513 |
|
| 2007 |
Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials. 28: 869-876. PMID 17055572 DOI: 10.1016/J.Biomaterials.2006.09.047 |
0.52 |
|
| 2006 |
Bagalkot V, Farokhzad OC, Langer R, Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angewandte Chemie (International Ed. in English). 45: 8149-52. PMID 17099918 DOI: 10.1002/Anie.200602251 |
0.457 |
|
| 2006 |
Farokhzad OC, Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆ Advanced Drug Delivery Reviews. 58: 1456-1459. PMID 17070960 DOI: 10.1016/J.Addr.2006.09.011 |
0.312 |
|
| 2006 |
Farokhzad OC, Dimitrakov JD, Karp JM, Khademhosseini A, Freeman MR, Langer R. Drug delivery systems in urology--getting "smarter". Urology. 68: 463-9. PMID 17010721 DOI: 10.1016/J.Urology.2006.03.069 |
0.424 |
|
| 2006 |
Farokhzad OC, Karp JM, Langer R. Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opinion On Drug Delivery. 3: 311-24. PMID 16640493 DOI: 10.1517/17425247.3.3.311 |
0.52 |
|
| 2006 |
Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proceedings of the National Academy of Sciences of the United States of America. 103: 6315-20. PMID 16606824 DOI: 10.1073/Pnas.0601755103 |
0.556 |
|
| 2005 |
Farokhzad OC, Khademhosseini A, Jon S, Hermmann A, Cheng J, Chin C, Kiselyuk A, Teply B, Eng G, Langer R. Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Analytical Chemistry. 77: 5453-9. PMID 16131052 DOI: 10.1021/Ac050312Q |
0.418 |
|
| 2004 |
Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Research. 64: 7668-72. PMID 15520166 DOI: 10.1158/0008-5472.Can-04-2550 |
0.489 |
|
| Show low-probability matches. |